
28 August 2008: Announcement no. 2, 2008: Zealand Pharma today announced that Dr. David H...
Zealand's Pipeline comprises 1 compound in phase III, 2 compounds in phase II, 3 compounds ...
Vision
To be the European technology leader in research and development of peptide drugs.
To bring innovative peptide drugs with significant therapeutic and commercial potential quickly and efficiently to the market to cover patients’ unmet clinical needs.
To have a strong and risk diverse product pipeline with products near to the market by 2010.
To provide a sustainable platform for efficient development of peptide drugs, using our proprietary technologies.
To form alliances whenever they serve our business purpose.
To keep certain marketing rights to our products that might allow us to establish own marketing organizations in certain territories.
To be a preferred employer through our values and the ‘way we work’.
Mission
The overall focus for Zealand is to create maximum value by bringing innovative peptide drugs with significant therapeutic and commercial potential quickly and efficiently to the market to cover patients unmet clinical needs.
Fill in the form below to tip a friend about this page.
When this page is updated you will be updated by e-mail.